Metal complexes of 5-carboxy-2-thiouracil with Mn(ll), Co(ll), Ni(ll), Cu(ll), Zn(ll) and Cd(ll) ions were synthesized, characterized, and subjected to a screening system for evaluation of antitumour activity against (S-180) tumour cells. The complexes were characterized by elemental analysis, infrared, electronic spectra, room temperature magnetic measurements and powder X-ray diffraction. The antitumour activity results indicate that some complexes have antitumour activity both in v_jx andj_q vitro against S-180 tumour cells.
. The bacteriostatic or bacteriocidal activities of 5CTU and scanty information on its metal complexes [2] as antitumour agent encouraged to undertake a systematic study of its metal complexes and to test the antitumour activity of synthesized compounds. The present paper describes the structural as well as the antitumour activity studies of Mn(II),Co(II), Ni(II), Cu(ll), Zn(ll) and Cd(ll) complexes with 5CTU.
Results and Discussion
The satisfactory elemental analyses have been obtained for all compounds. They display 1:1 stoichiometry. All the complexes are coloured except Zn(ll) and Cd(ll). They are insoluble in almost all common organic solvents except Mn(II) complex which is sparingly soluble in dimethylsulfoxide on heating.
Infrared spectra Thus the binding of 5CTU with metal ions is suggested through CO0 and C=S groups which have been confirmed on the basis of the presence of vM-0 and vM-S bands in the lower region of spectra [3] . Further it was found that none of the test compounds were toxic up to the dose of 50.0 mg/kg body weight except the complex containing Cd(II) ion (as observed by body weight change upt to six days of drug treatment). The compound Cd(II)-5CTU was found to be toxic even at the dose of 2.5 mg/kg body weight. The ligand 5CTU and its complexes were also tested for their inhibitory effect on 3H-thymidine,3H-uridine and 3H-leucine incorporation in S-1 80 tumour cells in vitro. Most of the compounds that caused inhibition of 3H-thymidine, 3H-uridine and 3H-leucine incorporation in S-180 tumour cells, also showed antitumour activity i___o_n v_ix.o_ (Table 3a , 3b, 3c). Thus it is concluded from the resluts obtained in the present study that all the complexes have octahedral structure. Regarding the antitumour activity study, the ligand 5CTU and its complexes with Co(II), Ni(II) and Vol. 5, No. 1, 1998 Synthesis, Characterization and Antitumour Activity of Metal Complexes of 5-Carboxy-2-Thiouracil hydrogen, and nitrogen were analyzed with a Perkin-Elmer model 240C elemental analyzer. The infrared spectra were obtained in Nujol on a Perkin-Elmer model 783 spectrophotometer in the 4000-200 cm -1 region. The electronic spectra of the complexes were recorded in Nujol with a UV/VIS-168A Shimadzu spectrophotometer at room temperature. The room temperature (298K) magnetic susceptibility measurements were made on Cahn Faraday magnetic susceptibility balance. X-ray powder diffraction data of the complexes were obtained on a Philips X-ray diffractometer PW1710 using CuKct radiation. Indexing of X-ray powder lines was done by Ito's method [9] .
Antitumour activity of the ligand 5CTU and its synthesized metal complexes were tested against Sarcoma-180 (S-180) tumour system both in vivo and in vitro according to the method described earlier [11] . Therapeutic effectiveness of each compound against tumour bearing mice was assessed from the T/C percentage which was calculated as follows:
Mean life span of treated mice* T/C% Mean life span of untreated mice * excluding tumour free survivors.
X 100
A T/C value of 115 indicates significant activity whereas > 125 indicates that complex is worthy of testing in other tumour systems [12] .
